vaccines

Congo to start using J&J Ebola vaccine in November
Congo to start using J&J Ebola vaccine in November
Yahoo/Reuters
Congo
JNJ
ebola virus
vaccines
Flag link:
Amid next-gen vaccine race, Merck says ex-employee bolted to Pfizer with 'thousands' of key documents
Amid next-gen vaccine race, Merck says ex-employee bolted to Pfizer with 'thousands' of key documents
Fierce Pharma
Merck
Pfizer
vaccines
trade secrets
pneumococcal disease
Flag link:
Large numbers of pregnant women not getting key vaccines, CDC says
Large numbers of pregnant women not getting key vaccines, CDC says
Stat
vaccines
pregnancy
CDC
Flag link:
Merck taps 4D pharma for bacterial vaccine R&D project
Merck taps 4D pharma for bacterial vaccine R&D project
Fierce Biotech
Merck
4D Pharma
vaccines
R&D
Flag link:
Icosavax raises $51M to take VLP RSV vaccine into humans
Icosavax raises $51M to take VLP RSV vaccine into humans
Fierce Biotech
Icosavax
vaccines
RSV
VLP
viruslike particle
IVX-121
Flag link:
Flu vaccine selections may be an ominous sign for this winter
Flu vaccine selections may be an ominous sign for this winter
Stat
vaccines
flu vaccines
CDC
influenza
Flag link:
Meissa raises $30M to take RSV vaccine into the clinic
Meissa raises $30M to take RSV vaccine into the clinic
Fierce Biotech
Meissa Vaccines
vaccines
RSV
clinical trials
Flag link:
FDA endorses Bavarian Nordic's monkeypox vaccine, marking world's first approval
FDA endorses Bavarian Nordic's monkeypox vaccine, marking world's first approval
Endpoints
Bavarian Nordic
monkeypox
vaccines
FDA
Africa
smallpox
Flag link:
Malaria Vaccine 30 Years And $1 Billion In The Making Now Deployed In Third Country
Malaria Vaccine 30 Years And $1 Billion In The Making Now Deployed In Third Country
Forbes
Africa
malaria
vaccines
GSK
Gates Foundation
Malawi
Ghana
Kenya
Flag link:
Herpes Vaccine Candidate Moves Closer To Human Trials
Herpes Vaccine Candidate Moves Closer To Human Trials
Forbes
herpes
vaccines
University of Pennsylvania
MRNA
Flag link:
HIV vaccine shows signs of cross-subtype protection
HIV vaccine shows signs of cross-subtype protection
Fierce Biotech
vaccines
HIV
ALVAC‐HIV
Sanofi Pasteur
GSK
JNJ
South Africa
clinical trials
Flag link:
Themis raises €40M to run phase 3 chikungunya vaccine trial
Themis raises €40M to run phase 3 chikungunya vaccine trial
Fierce Biotech
Themis
Merck
chikungunya virus
vaccines
clinical trials
Flag link:
Merck's Ebola vaccine tees up FDA date, aiming for first status
Merck's Ebola vaccine tees up FDA date, aiming for first status
Fierce Biotech
Merck
ebola virus
vaccines
FDA
V920
Flag link:
New evidence shows why the HPV vaccine is as important for boys as girls
New evidence shows why the HPV vaccine is as important for boys as girls
Stat
HPV
Gardasil
vaccines
Flag link:
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Pharmaforum
Alzheimer's disease
drug development
vaccines
Axon
Flag link:
Pfizer touts successor to Prevnar 13
Pfizer touts successor to Prevnar 13
Biopharma Dive
Pfizer
Prevnar 13
vaccines
clinical trial
pneumococcal disease
Flag link:
HHS pledges $23M to develop Merck's experimental Ebola vaccine
HHS pledges $23M to develop Merck's experimental Ebola vaccine
Beckers Hospital Review
HHS
vaccines
Merck
V920
ebola virus
Flag link:
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Stat
Lyme disease
vaccines
drug development
LYMErix
VLA15
Valneva
Flag link:
Philippines officials nix Sanofi's attempt to bring Dengvaxia back to market
Philippines officials nix Sanofi's attempt to bring Dengvaxia back to market
Fierce Pharma
Sanofi
Dengvaxia
vaccines
dengue
Philippines
Flag link:
Merck teams up with Themis to develop vaccines
Merck teams up with Themis to develop vaccines
Fierce Biotech
Merck
vaccines
Themis Bioscience
R&D
Flag link:

Pages